Distinguished Doctors Converged at Royal Cliff and PEACH for the 39th Annual Meeting of the Royal College of Orthopedic Surgeons of Thailand

Food and Healthcare Press Releases Tuesday November 28, 2017 10:25
Bangkok--28 Nov--Royal Cliff Hotels Group

The award-winning Royal Cliff Hotels Group and Pattaya Exhibition And Convention Hall (PEACH) was once again the chosen venue for the 39th Annual Meeting of Royal College of Orthopedic Surgeons of Thailand (RCOST).

RCOST spent 4 days at the award-winning resort where delegates experienced an exchange of current scientific and clinical information for regional and global orthopaedic communities. The annual RCOST meetings have always received tremendous interest in terms of participation and quality of contributions among ASEAN and Asian orthopaedic surgeons. This year's successful meeting ended with an unforgettable Thank you dinner held at Royal Cliff's popular Chinese restaurant, Huang Chao – Royal Cantonese Cuisine.

Situated on a 64 acre private parkland estate overlooking the stunning Gulf of Thailand, the Royal Cliff Hotels Group has been honored with multiple awards and recognition from organizations of national and international repute. It is home to four award winning 5-star hotels offering a sensory experience defined profoundly by its style, culture and elegance - all presented with the distinctive spirit of the State of Exclusivity and Fascination.

PEACH is a world-renowned award-winning convention facility under the flagship of the Royal Cliff Hotels Group. Offering an ideal location, modern facility and professional service, it is the perfect venue to hold any kind of event and can accommodate up to 10,062 people theatre-style. Want to hold your next event at PEACH? Request for a proposal by contacting our Sales Managers at (+66) 38 250 421 Ext: 2845 or emailing: mice@royalcliff.com.

For more information on the Royal Cliff Hotels Group and Pattaya Exhibition And Convention Hall (PEACH), please visit www.royalcliff.com and www.peachthailand.com

Latest Press Release

Whisk#s AI-Powered Culinary Coach Named as Winner of Ascensia Diabetes Challenge

Today, at the American Diabetes Association's 78th Scientific Sessions in Orlando, Florida, Ascensia Diabetes Care has revealed that UK-based Whisk have been selected as the winner of the Ascensia Diabetes Challenge, a global innovation competition that...

Significant Blood Sugar Improvement With Xultophy(R) Compared to Insulin Glargine U-100 When Used as Add-On to Oral Diabetes Medications

Adults with type 2 diabetes treated with Xultophy(R) (insulin degludec and liraglutide injection) also experienced no change in body weight, lower rates of hypoglycaemia and a lower insulin dose at 26 weeks Xultophy(R) (insulin degludec and liraglutide...

Tresiba(R) Demonstrated Significantly Improved Blood Sugar Control and Lower Rates of Hypoglycaemia Versus Insulin Glargine U300 in Real-World Evidence Study

Adults with type 2 diabetes treated with Tresiba(R) (insulin degludec injection) had a significant reduction in HbA1c and a 30% lower rate of hypoglycaemic episodes after starting basal insulin Findings from CONFIRM - a large real-world evidence (RWE)...

Ozempic(R) Provided Greater Weight Reductions for Adults With a Baseline BMI ?25kg/m2 Than Those With Lower Baseline BMI 25kg/m2, in a SUSTAIN 7 Post-hoc Analysis

Ozempic(R) (semaglutide) 0.5 mg or 1.0 mg provided greater weight reductions vs dulaglutide 0.75 mg or 1.5 mg, respectively, in adults with type 2 diabetes, regardless of baseline body mass index (BMI), with the greatest reductions occurring in adults...

Oral Semaglutide Demonstrated Significant Reduction in Blood Sugar vs Placebo in PIONEER 1 Trial

Oral semaglutide, an investigational GLP-1 analogue taken as a once-daily tablet, achieved significant reductions in blood sugar versus placebo in adults with type 2 diabetes, according to findings from the PIONEER 1 phase 3a trial. The trial evaluated...

Related Topics